EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Double-blind randomised controlled trial of an emollient cream with and without 1 % supercritical CO 2 extract of Calendula officinalis in contact dermatitis

Mia Šušak Crnčević, Toni Durdov iD, Doris Rušić iD, Lara Ramić, Ana Ćosić, Josipa Bukić iD, Stela Jokić iD, Krunoslav Aladić iD

Acta Pharmaceutica · 01.12.2025 · 75 (4) · 699-708

DOI: 10.2478/acph-2025-0035 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Pharmaceutica, online erschienen am 13.01.2026. Verfasst von Mia Šušak Crnčević und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy University of Split School of Medicine, 21000 Split, Croatia. Hauptthemen laut MEDLINE: Calendula, Plant Extracts, Emollients, Skin Cream. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This double-blind randomised controlled trial aimed to evaluate the efficacy of an emollient cream with and without 1 % supercritical CO 2 extract of Calendula officinalis in contact dermatitis. Twenty healthy volunteers without pre-existing dermatological conditions participated in this single-centre study. Each participant’s forearm was divided into three test sites: control (no treatment), placebo (base emollient), and intervention (calendula cream). The study employed random allocation of test sites using Microsoft Excel software. Both investigators and participants were blinded to the treatment assignments. The main outcomes were changes in skin hydration and transepidermal water loss (TEWL), measured with non-invasive probes (Corneometer CM 825, Tewameter TM 300), and erythema measured by Mexameter MX 18. Following irritant exposure, all sites showed increased TEWL and reduced hydration, confirming skin barrier impairment. The intervention site demonstrated significantly greater hydration compared with both the control ( p = 0.017) and placebo sites ( p = 0.035) on day 4, with this improvement persisting on day 8 ( p = 0.043). TEWL values at the intervention site were significantly lower than control on day 3 ( p = 0.022), indicating faster barrier recovery. No significant differences in erythema were observed between groups, and no adverse events occurred. Results of this study indicate that the addition of 1 % Calendula officinalis extract to an emollient cream enhanced skin hydration and accelerated recovery after irritant exposure, suggesting potential benefit in managing contact dermatitis with non-pharmacological skincare formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalendulaPlant ExtractsEmollientsSkin CreamDermatitis, ContactHumansAdultMaleFemaleDouble-Blind MethodWater Loss, InsensibleYoung AdultCarbon DioxideErythemaMiddle AgedSkinTreatment Outcome

Stichwörter der Autor:innen

calendulacontact dermatitisskin barrierskin hydrationsupercritical extractiontransepidermal water loss

Substanzen

Plant ExtractsEmollientsCarbon Dioxide

Autor:innen und Institutionen

  • Department of Pharmacy University of Split School of Medicine, 21000 Split, Croatia.
  • Department of Laboratory Medicine and Pharmacy, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
  • Faculty of Food Technology Osijek Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.

ORCID-Profile: Toni Durdov, Doris Rušić, Josipa Bukić, Stela Jokić, Krunoslav Aladić

Zitieren

APA

Crnčević, M. Š., Durdov, T., Rušić, D., Ramić, L., Ćosić, A., Bukić, J., Jokić, S., & Aladić, K. (2025). Double-blind randomised controlled trial of an emollient cream with and without 1 % supercritical CO 2 extract of Calendula officinalis in contact dermatitis. Acta Pharmaceutica, 75(4), 699-708. https://doi.org/10.2478/acph-2025-0035

Vancouver

Crnčević MŠ, Durdov T, Rušić D, Ramić L, Ćosić A, Bukić J, et al. Double-blind randomised controlled trial of an emollient cream with and without 1 % supercritical CO 2 extract of Calendula officinalis in contact dermatitis. Acta Pharmaceutica. 2025;75(4):699-708. doi:10.2478/acph-2025-0035

BibTeX
@article{Crnevi2025,
  author = {Crnčević, Mia Šušak and Durdov, Toni and Rušić, Doris and Ramić, Lara and Ćosić, Ana and Bukić, Josipa and Jokić, Stela and Aladić, Krunoslav},
  title = {Double-blind randomised controlled trial of an emollient cream with and without 1 % supercritical CO 2 extract of Calendula officinalis in contact dermatitis},
  journal = {Acta Pharmaceutica},
  year = {2025},
  volume = {75},
  number = {4},
  pages = {699--708},
  doi = {10.2478/acph-2025-0035}
}
Kostenlos starten →